Quantcast

Latest chemotherapy Stories

2014-03-05 12:27:50

The Animal Medical Center Select's Equashield to Minimize Hazardous Drug Exposure for Staff and Patients NEW YORK and PORT WASHINGTON, New York, March 5, 2014 /PRNewswire/ -- Equashield (http://www.equashield.com), the leading provider of Closed System Transfer Devices (CSTDs) for hazardous drugs, and The Animal Medical Center (AMC) in New York City (http://www.amcny.org), one of the leading academic veterinary hospitals in the United States, announced today that Equashield's...

2014-03-05 10:59:39

Many breast cancer survivors experience fatigue and other debilitating symptoms that persist months to years after their course of treatment has ended. Now researchers at the Winship Cancer Institute of Emory University have found clues that may explain how these symptoms can linger. Chemotherapy, one of the major treatments for breast cancer, can leave a long-lasting epigenetic imprint in the DNA of breast cancer patients’ blood cells. That imprint is associated with biological signs of...

2014-03-05 10:57:36

An experimental drug aimed at restoring the immune system's ability to spot and attack cancer halted cancer progression or shrank tumors in patients with advanced melanoma, according to a multisite, early-phase clinical trial at Johns Hopkins Kimmel Cancer Center and 11 other institutions. All patients had experienced disease progression despite prior systemic therapies, and most had received two or more prior treatments. Patients who showed responses to the drug, nivolumab (anti-PD-1;...

2014-03-03 23:22:47

Researchers say reduced white blood cell count with chemotherapy could be corrected with appropriate medication. Raleigh, NC (PRWEB) March 03, 2014 Researchers examining the rates of grade 3 and 4 neutropenia, a side effect of chemotherapy, say patients who are younger than 65 are less likely to receive prophylactic treatment for the problem. Neutropenia is characterized by an abnormally low number of neutrophils, a type of circulating white blood cell that destroys bacteria in the blood....

2014-03-03 15:25:51

Researchers from UCLA's Jonsson Comprehensive Cancer Center have developed an innovative cancer-fighting technique in which custom-designed nanoparticles carry chemotherapy drugs directly to tumor cells and release their cargo when triggered by a two-photon laser in the infrared red wavelength. The research findings by UCLA's Jeffrey Zink, a professor of chemistry and biochemistry, and Fuyu Tamanoi, a professor of microbiology, immunology and molecular genetics, and their colleagues were...

2014-03-03 08:31:39

Shortage Could Impact Treatment of Most Chemotherapy Patients WASHINGTON, March 3, 2014 /PRNewswire-USNewswire/ -- The Community Oncology Alliance (COA) has released the results of its IV Fluid Shortage Survey. Sixty-six practices from across the country were surveyed. The results revealed: -- 85% of the practices surveyed have received warnings from multiple manufacturers and/or have been impacted by the shortage of IV fluids -- 44% of the practices surveyed have adjusted...

Better Cancer Treatments May Follow Research In Outer Space
2014-02-28 10:25:13

Rebekah Eliason for redOrbit.com – Your Universe Online Although a necessary evil for a vast amount of people, systemic cancer treatment is an invasive procedure with devastating side effects. People undergoing cancer treatment often experience nausea, immune suppression, hair loss and organ failure. All of this is endured with the hope of exterminating the cancerous tissues in the body. If a treatment were developed to specifically target the cancerous tissue instead of treating the...

2014-02-27 23:27:37

A Belgian research team says new and experimental treatment approaches are poised to extend mesothelioma survival in the future. Raleigh, NC (PRWEB) February 27, 2014 Cancer researchers at Belgium’s Antwerp University Hospital say emerging mesothelioma treatments like hyperthermic intrapleural chemotherapy, immunotherapy, and photodynamic therapy are likely to transform multi-modal treatment of the cancer. As Surviving Mesothelioma reports, the team’s newly- published article in the...

2014-02-27 08:30:00

Patient Recruitment Now Underway at Treatment Centers Across the United States WOODCLIFF LAKE, N.J., Feb. 27, 2014 /PRNewswire/ -- Eisai Inc. today announced the start of a large, randomized Phase 3 trial to compare the efficacy, safety and tolerability of eribulin mesylate to standard weekly paclitaxel as a first- or second- line treatment for HER2-negative locally recurrent or metastatic breast cancer (MBC). Recruitment is currently active for this multicenter study, conducted in...

2014-02-26 08:29:14

Test Offering Through Parkway Cancer Centre Supports Company's Growth in International Markets HACKENSACK, N.J., Feb. 26, 2014 /PRNewswire/ -- Champions Oncology (OTC: CSBR), a company engaged in the development of advanced technology solutions and services to personalize the development and use of oncology drugs, today announced that a leading hospital network in Asia, Parkway Cancer Centre (PCC), will begin offering Champions TumorGrafts(TM) to cancer patients at its three...


Latest chemotherapy Reference Libraries

Intravenous Therapy
2013-04-30 13:16:16

Intravenous therapy, commonly known as IV therapy, is known as the administration of a liquid substance directly into a vein. It is also known as drip therapy, because most often the liquid is suspended above the IV site by an infusion pump, and runs through a drip chamber, which prevents air from entering the line. IVs are the preferred method of drug administration in hospital settings because they are the fastest known route of getting medication to the body. Intravenous therapy can also...

Antiviral Chemistry & Chemotherapy
2012-04-25 09:59:26

Antiviral Chemistry & Chemotherapy is a peer-reviewed academic journal published bi-monthly by International Medical Press in London since 1997. When founded in January 1990, it was published by Blackwell Science. The current editor-in-chief is Hugh J. Field of University of Cambridge, UK. The journal publishes primary papers and reviews on all aspects of the preclinical development of antiviral agents, including their chemical synthesis, biochemistry, pharmacology, mode of action and...

More Articles (2 articles) »
Word of the Day
drawcansir
  • A blustering, bullying fellow; a pot-valiant braggart; a bully.
This word is named for Draw-Can-Sir, a character in George Villiers' 17th century play The Rehearsal.
Related